Scott Wapner and the Investment Committee discuss the rally amid potential tariffs coming with the new administration. Plus, Amgen on pace for its worst day since October, 2000, it’s our Chart of the Day, the desk debates the name and the biotech sector. And late, the Investment Committee debate the latest Calls of the Day on Zoom and Delta.
Activity